If you're apprehensive about getting an intravitreal injection for age-related macular degeneration (AMD), you're not alone. Ophthalmologist Monika Fleckenstein, MD, explains the procedure, how it can ...

Repeated intravitreal injections of the vascular endothelial growth factor (VEGF) inhibitor bevacizumab (Avastin) may increase the risk of uncontrolled glaucoma, according to a Canadian study in JAMA ...

Please provide your email address to receive an email when new articles are posted on . In the past decade, intravitreal injections have transformed the way that we treat retinal disease, particularly ...

Implantation in the eye of the port delivery system loaded with a bolus of the antivascular endothelial growth factor ranibizumab was associated with similar improvements in visual acuity after 2 ...

Patients completed a questionnaire that assessed the impact of intravitreal injections on quality of life This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, ...

A low risk of adverse safety outcomes was observed in anti–vascular endothelial growth factor (VEGF) intravitreal injections performed in office-based and operating room settings, with a higher rate ...